Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01763814Not ApplicableCompleted

Three Different Approaches for Ultrasound Guided Femoral Nerve Block for Patients Undergoing Total Knee Arthroplasty

Role: lead

NCT01776671Phase 3Unknown

Once Daily Gabapentin in the Treatment of Post Amputation Pain

Role: lead

NCT01761604Not ApplicableCompleted

A Nasal Applicator for the Treatment of Trigeminal Neuralgia

Role: lead

NCT01764932Not ApplicableUnknown

Accuracy of the Thoracic Epidural Catheter Insertion Confirmed by Fluoroscopic Imaging

Role: lead

All 4 trials loaded